Abstract
CD46 is a complement regulator with important roles related to the immune response. CD46 functions as a pathogen receptor and is a potent costimulator for the induction of interferon-γ (IFN-γ)-secreting effector T helper type 1 (TH1) cells and their subsequent switch into interleukin 10 (IL-10)-producing regulatory T cells. Here we identified the Notch family member Jagged1 as a physiological ligand for CD46. Furthermore, we found that CD46 regulated the expression of Notch receptors and ligands during T cell activation and that disturbance of the CD46-Notch crosstalk impeded induction of IFN-γ and switching to IL-10. Notably, CD4+ T cells from CD46-deficient patients and patients with hypomorphic mutations in the gene encoding Jagged1 (Alagille syndrome) failed to mount appropriate TH1 responses in vitro and in vivo, which suggested that CD46-Jagged1 crosstalk is responsible for the recurrent infections in subpopulations of these patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Liszewski, M.K., Post, T.W. & Atkinson, J.P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9, 431–455 (1991).
Cattaneo, R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 78, 4385–4388 (2004).
Astier, A., Trescol-Biemont, M.C., Azocar, O., Lamouille, B. & Rabourdin-Combe, C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 164, 6091–6095 (2000).
Cardone, J. et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11, 862–871 (2010).
Cope, A., Le Friec, G., Cardone, J. & Kemper, C. The Th1 life cycle: molecular control of IFN-γ to IL-10 switching. Trends Immunol. 32, 278–286 (2011).
Casasnovas, J.M., Larvie, M. & Stehle, T. Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J. 18, 2911–2922 (1999).
Arnberg, N. Adenovirus receptors: implications for tropism, treatment and targeting. Rev. Med. Virol. 19, 165–178 (2009).
Riley, R.C., Tannenbaum, P.L., Abbott, D.H. & Atkinson, J.P. Cutting edge: inhibiting measles virus infection but promoting reproduction: an explanation for splicing and tissue-specific expression of CD46. J. Immunol. 169, 5405–5409 (2002).
Amsen, D., Antov, A. & Flavell, R.A. The different faces of Notch in T-helper-cell differentiation. Nat. Rev. Immunol. 9, 116–124 (2009).
Fremeaux-Bacchi, V. et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 17, 2017–2025 (2006).
Couzi, L. et al. Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair. Am. J. Kidney Dis. 52, e5–e9 (2008).
Vajro, P., Ferrante, L. & Paolella, G. Alagille syndrome: An overview. Clin. Res. Hepatol. Gastroenterol. 36, 275–277 (2012).
Cordle, J. et al. A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat. Struct. Mol. Biol. 15, 849–857 (2008).
Greig, J.A. et al. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Mol. Ther. 17, 1683–1691 (2009).
Tsujimura, A. et al. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem. J. 330, 163–168 (1998).
Fernández-Centeno, E., de Ojeda, G., Rojo, J.M. & Portoles, P. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. J. Immunol. 164, 4533–4542 (2000).
Grzesiek, S. & Bax, A. Amino acid type determination in the sequential assignment procedure of uniformly 13C/15N-enriched proteins. J. Biomol. NMR 3, 185–204 (1993).
Kemper, C. & Atkinson, J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 7, 9–18 (2007).
Kemper, C. et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388–392 (2003).
Kopan, R. & Ilagan, M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216–233 (2009).
Rutz, S. et al. Notch regulates IL-10 production by T helper 1 cells. Proc. Natl. Acad. Sci. USA 105, 3497–3502 (2008).
Ni Choileain, S. et al. The dynamic processing of CD46 intracellular domains provides a molecular rheostat for T cell activation. PLoS ONE 6, e16287 (2011).
Cardone, J., Al-Shouli, S. & Kemper, C. A novel role for CD46 in wound repair in. Front Immun. 2, 28 (2011).
Fang, C.J. et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 111, 624–632 (2008).
Romagnani, S. Th1/Th2 cells. Inflamm. Bowel Dis. 5, 285–294 (1999).
Fuchs, A., Atkinson, J.P., Fremeaux-Bacchi, V. & Kemper, C. CD46-induced human Treg enhance B-cell responses. Eur. J. Immunol. 39, 3097–3109 (2009).
Liao, W., Lin, J.X. & Leonard, W.J. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr. Opin. Immunol. 23, 598–604 (2011).
Nervi, B. et al. Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Exp. Hematol. 35, 1823–1838 (2007).
Liu, J., Sato, C., Cerletti, M. & Wagers, A. Notch signaling in the regulation of stem cell self-renewal and differentiation. Curr. Top. Dev. Biol. 92, 367–409 (2010).
Oda, T. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet. 16, 235–242 (1997).
Quiros-Tejeira, R.E. et al. Variable morbidity in Alagille syndrome: a review of 43 cases. J. Pediatr. Gastroenterol. Nutr. 29, 431–437 (1999).
Robinson, M. et al. An analysis of the normal ranges of lymphocyte subpopulations in children aged 5–13 years. Eur. J. Pediatr. 155, 535–539 (1996).
Bhavsar, P.J., Infante, E., Khwaja, A. & Ridley, A.J. Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration. Oncogene (2012).
del Álamo, D., Rouault, H. & Schweisguth, F. Mechanism and significance of cis-inhibition in Notch signalling. Curr. Biol. 21, R40–R47 (2011).
Alford, S.K., Longmore, G.D., Stenson, W.F. & Kemper, C. CD46-induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells. J. Immunol. 181, 2544–2555 (2008).
Bikker, A., Hack, C.E., Lafeber, F.P. & van Roon, J.A. Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. Curr. Pharm. Des. 18, 2347–2356 (2012).
Gregory, S.G. et al. Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 39, 1083–1091 (2007).
Hafler, D.A. et al. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357, 851–862 (2007).
Astier, A.L., Meiffren, G., Freeman, S. & Hafler, D.A. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116, 3252–3257 (2006).
Adler, S.H. et al. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J. Immunol. 171, 2896–2903 (2003).
Adams, W.C. et al. Attenuation of CD4+ T-cell function by human adenovirus type 35 is mediated by the knob protein. J. Gen. Virol. 93, 1339–1344 (2012).
Adams, W.C. et al. Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation. Proc. Natl. Acad. Sci. USA 108, 7499–7504 (2011).
Gibb, A.L., Freeman, A.M., Smith, R.A., Edmonds, S. & Sim, E. The interaction of soluble human complement receptor type 1 (sCR1, BRL55730) with human complement component C4. Biochim. Biophys. Acta 1180, 313–320 (1993).
Marley, J., Lu, M. & Bracken, C. A method for efficient isotopic labeling of recombinant proteins. J. Biomol. NMR 20, 71–75 (2001).
White, J. et al. Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli. Protein Sci. 13, 2406–2415 (2004).
Roversi, P. et al. Structures of the rat complement regulator CrrY. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 67, 739–743 (2011).
Wang, G., Liszewski, M.K., Chan, A.C. & Atkinson, J.P. Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J. Immunol. 164, 1839–1846 (2000).
Schleucher, J. et al. A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients. J. Biomol. NMR 4, 301–306 (1994).
Yamazaki, T., Lee, W., Arrowsmith, C.H., Muhandiram, D.R. & Kay, L.E. A Suite of triple-resonance NMR experiments for the backbone assignment of N-15, C-13, H-2 labeled proteins with high-sensitivity. J. Am. Chem. Soc. 116, 11655–11666 (1994).
Acknowledgements
We thank the CD46-deficient patients and patients with Alagille syndrome for their support, and A. Hayday for data discussions. Supported by the Medical Research Council (G1002165 to C.K.), the European Union Framework Programme 7 (Innovative Medicines Initiative “Be The Cure” project with C.K. as lead researcher), the Medical Research Council Centre for Transplantation (Guy's Hospital, King's College), the Department of Health, the National Institute for Health Research Biomedical Research Centre (for Guy's & St. Thomas' National Health Service Foundation Trust in partnership with King's College London and King's College Hospital National Health Service Foundation Trust), the Wellcome Trust (097928/A/08/Z to S.M.L. and P.A.H.), the German Research Foundation (GRK1727 TP8 and SFB/TR22 A21 to J.K.) and the European Research Council ('SomaBio' to S.N.W.).
Author information
Authors and Affiliations
Contributions
A.B. and P.A.H. contributed equally to this work. G.L.F. designed and did experiments and wrote the manuscript; D.S. did surface plasmon resonance and nuclear magnetic resonance spectroscopy experiments; P.W. and C.C. generated recombinant Notch and Jagged1 proteins; C.M.K. and J.K. did the super-resolution microscope studies and edited the manuscript; S.A.-T.S., A.B., C.D., L.C. and V.F.-B. provided blood samples from patients and discussed the data; A.L. did the graft-versus-host disease experiments and discussed data; L.B. and M.J.D. designed the RT-PCR experiments and discussed the data; T.M. and R.A.S. generated soluble CD46 and soluble complement receptor 1 and discussed data; S.N.W. provided mice with transgenic expression of human CD46 and edited the paper; J.M.M. did surface plasmon resonance experiments and edited the paper; P.A.H. provided recombinant Notch and Jagged proteins, designed experiments and edited the paper; S.M.L. designed the surface plasmon resonance and nuclear magnetic resonance experiments, provided recombinant CD46 proteins and edited the manuscript; and C.K. conceived of and designed the study, did experiments and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–6 and Tables 1–2 (PDF 2698 kb)
Rights and permissions
About this article
Cite this article
Le Friec, G., Sheppard, D., Whiteman, P. et al. The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat Immunol 13, 1213–1221 (2012). https://doi.org/10.1038/ni.2454
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2454
This article is cited by
-
Complosome — the intracellular complement system
Nature Reviews Nephrology (2023)
-
Immunologic and Genetic Contributors to CD46-Dependent Immune Dysregulation
Journal of Clinical Immunology (2023)
-
Lupus nephritis with corticosteroid responsiveness: molecular changes of CD46-mediated type 1 regulatory T cells
Pediatric Research (2022)
-
Potential diagnostic and prognostic of efferocytosis-related unwanted soluble receptors/ligands as new non-invasive biomarkers in disorders: a review
Molecular Biology Reports (2022)
-
A Notch/STAT3-driven Blimp-1/c-Maf-dependent molecular switch induces IL-10 expression in human CD4+ T cells and is defective in Crohn´s disease patients
Mucosal Immunology (2022)